Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04558307 Completed - Clinical trials for Coronavirus Disease (COVID-19)

Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations

Start date: June 3, 2020
Phase:
Study type: Observational

The purpose of this study is to assess the feasibility of establishing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing at a federally-qualified health center (FQHC) during a global health crisis to mitigate COVID-19 disparities in socioeconomically disadvantaged populations.

NCT ID: NCT04557358 Completed - Clinical trials for Rheumatoid Arthritis

Impact in the Medical Care Among the Rheumatic Diseases Patients in a Hospital in México During COVID-19 Pandemic

Start date: October 1, 2020
Phase:
Study type: Observational

The National Institute of Medical Sciences and Nutrition is a national reference center for rheumatic diseases that belongs to The National Institutes of Health, and has Federal founding. More than 8,000 patients with a wide variety of rheumatologic diagnosis receive medical care. On March 2020, the WHO announced COVID-19 outbreak a pandemic. The first case was registered in Mexico on February 2020. In March 2020, the Mexican Government requested that our Institution should restrict health care to exclusively COVID-19 patients; accordingly, outpatient consultations were, and up to August 2020 still, hold on. Meanwhile, when possible, the Department of Immunology and Rheumatology has implemented an "on-demand", non-organized patient´s health care, through email and phone contact; nonetheless, and due to the middle-low socioeconomic status of most of our patients and limited technical resources available at our Institution, the attempt has been challenging.

NCT ID: NCT04557241 Completed - Clinical trials for COVID19 Behavioral Prophylaxis

Brief Informational Intervention for COVID-19 Misinformation Prophylaxis

Start date: January 14, 2020
Phase: N/A
Study type: Interventional

As the coronavirus disease 2019 (COVID-19) pandemic has continued to affect life in the United States, the important role of non-pharmaceutical preventive behaviors (such as wearing a face mask) in reducing harm has become clear. In parallel to the pandemic, researchers have observed an "infodemic" of misinformed or inconsistent narratives about COVID-19. There is growing evidence that misinformed COVID-19 narratives are associated with a wide variety of undesirable behavior (e.g., burning down cell towers). Further, individuals' adherence to recommended COVID-19 preventive guidelines has been inconsistent, and such mandates have engendered opposition and controversy. Recent research suggests the possibility that trust in science and scientists may be an important thread to weave throughout these seemingly disparate components of the modern public health landscape. Thus, this paper describes the protocol for a randomized trial of a brief, digital intervention to increase trust in science. The objective of this trial is to examine if exposure to a curated infographic can increase trust in science, reduce believability of misinformed narratives, and increase likelihood to engage in preventive behaviors.

NCT ID: NCT04556513 Completed - Covid19 Clinical Trials

Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status

RECOVIDS
Start date: September 18, 2020
Phase:
Study type: Observational

In this study, the investigators are attempting to evaluate the influence of socio-economic factors on the functional recovery (physical and psychological) of patients who developed ARDS after a COVID-19 infection, with the aim of offering personalized medical and social follow-up and support measures in order to avoid medium- and long-term complications, which can result in handicaps, reduced quality of life, and a higher risk of death.

NCT ID: NCT04556318 Completed - Covid19 Clinical Trials

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Start date: September 23, 2020
Phase:
Study type: Observational

Breath analysis is the evaluation of exhaled air of humans. It aims to get information about the clinical status of a human being by monitoring its volatile organic compounds (VOCs) in exhaled air. In this feasibility study it is intended to find specific biomarker(s) in exhaled breath indicating an infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2).

NCT ID: NCT04555213 Completed - Covid19 Clinical Trials

A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19

NOXCOVID
Start date: September 30, 2020
Phase: Phase 1
Study type: Interventional

Phase Ib, open-label, multicenter, study of NOX66, given rectally to hospitalized patients with moderate systemic illness due to COVID-19 infection at high risk of developing severe sepsis / septic shock.

NCT ID: NCT04555187 Completed - Covid19 Clinical Trials

Cardiovascular Risk Stratification in Covid-19

CaVaR-Co19
Start date: June 8, 2020
Phase:
Study type: Observational

This retrospective double-cohort study seeks to: 1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and 2. Develop a method of cardiovascular risk stratification in COVID-19

NCT ID: NCT04555148 Completed - Covid19 Clinical Trials

COVIDIG (COVID-19 Hyper-ImmunoGlobulin)

Start date: September 19, 2020
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of 5131A for hospitalized patients of COVID-19.

NCT ID: NCT04555005 Completed - COVID-19 Clinical Trials

Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19

Start date: March 10, 2020
Phase: N/A
Study type: Interventional

The COVID-19 outbreak is having an impact on the well-being of healthcare workers. Previous reports on pandemics show that such an impact may last beyond the time of the outbreak. Mindfulness-based interventions help healthcare professionals to reduce stress and may foster resilience and recovery, although they have never been tested in a context such as the current one. This single-arm trial explores the acceptability, safety and usefulness of an on-site, brief Mindfulness-based intervention to reduce stress for front line health workers during a crisis.

NCT ID: NCT04554979 Completed - Covid19 Clinical Trials

COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience

Start date: June 1, 2020
Phase:
Study type: Observational

The present study conducted to correlate symptoms not only constitutional and respiratory, but GIT as a principle presentation, with laboratory markers and COVID-19 severe acute respiratory syndrome (SARS-COV2) disease outcomes, as the duration of symptoms varies substantially between patients; the investigators undertook this study to determine the optimal time to predict COVID-19 outcomes based on real-time experience.